Edition:
United States

Formycon AG (FYB.DE)

FYB.DE on Xetra

35.00EUR
21 Aug 2018
Change (% chg)

€0.00 (+0.00%)
Prev Close
€35.00
Open
€34.40
Day's High
€35.00
Day's Low
€34.40
Volume
418
Avg. Vol
6,196
52-wk High
€39.35
52-wk Low
€28.20

Chart for

About

Formycon AG is a Germany-based company engaged in the development of biological therapeutics. The Company's business activities are focused on the development and marketing of biopharmaceuticals that are similar to existing drugs, for which the patent protection is expiring, as well as the provision of contract services. It is... (more)

Overall

Beta: 1.47
Market Cap(Mil.): €329.79
Shares Outstanding(Mil.): 9.42
Dividend: --
Yield (%): --

Financials

  FYB.DE Industry Sector
P/E (TTM): -- 98.72 30.39
EPS (TTM): -0.18 -- --
ROI: -6.04 0.92 12.61
ROE: -6.59 -0.89 14.80

BRIEF-Formycon FY Net Loss Of EUR 1.58 Mln

* INCREASED FY TURNOVER BY A GOOD 48 PERCENT COMPARED TO PREVIOUS YEAR TO EURO 29.00 MILLION (2016: 19.53 MILLION)

May 07 2018

BRIEF-Formycon Says Biosimilar Candidate FYB201 Shows Efficacy Comparable To Reference Product In Phase III Study

* BIOSIMILAR CANDIDATE FYB201 SHOWS EFFICACY COMPARABLE TO REFERENCE PRODUCT IN PHASE III STUDY Source text for Eikon: Further company coverage: (Gdynia Newsroom)

May 02 2018

Earnings vs. Estimates